☰

Martin Lundblad - Publications

Affiliations: 
Neurobiology, Experimental Medical Sciences, Lund University Lund University, Lund, Skåne län, Sweden 
Area:
Parkinson's disease, L-DOPA induced dyskinesia, Amperometry,
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lundblad M, Price DA, Burmeister JJ, Quintero JE, Huettl P, Pomerleau F, Zahniser NR, Gerhardt GA. Tonic and Phasic Amperometric Monitoring of Dopamine Using Microelectrode Arrays in Rat Striatum Applied Sciences. 10: 6449. DOI: 10.3390/app10186449  0.718
2017 Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 28900002 DOI: 10.1073/Pnas.1710442114  0.382
2016 Aldrin-Kirk P, Heuer A, Wang G, Mattsson B, Lundblad M, Parmar M, Björklund T. DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor. Neuron. PMID 27161524 DOI: 10.1016/J.Neuron.2016.04.017  0.419
2015 Nordström U, Beauvais G, Ghosh A, Pulikkaparambil Sasidharan BC, Lundblad M, Fuchs J, Joshi RL, Lipton JW, Roholt A, Medicetty S, Feinstein TN, Steiner JA, Escobar Galvis ML, Prochiantz A, Brundin P. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Neurobiology of Disease. 73: 70-82. PMID 25281317 DOI: 10.1016/J.Nbd.2014.09.012  0.431
2015 Aldrin-Kirk P, Heuer A, Mattsson B, Wang G, Lundblad M, Parmar M, Björklund T. 18. Novel Approach Using Fetal Dopaminergic Grafts In Situ Transduced with AAV-DREADDs Significantly Increases Behavioral Motor Recovery in a Rat Model of Parkinson's Disease Molecular Therapy. 23: S8-S9. DOI: 10.1016/S1525-0016(16)33622-X  0.465
2014 Pereira M, Pfisterer U, Rylander D, Torper O, Lau S, Lundblad M, Grealish S, Parmar M. Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. Scientific Reports. 4: 6330. PMID 25208484 DOI: 10.1038/Srep06330  0.693
2014 Fuqua JL, Littrell OM, Lundblad M, Turchan-Cholewo J, Abdelmoti LG, Galperin E, Bradley LH, Cass WA, Gash DM, Gerhardt GA. Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides. 54: 1-8. PMID 24406899 DOI: 10.1016/J.Peptides.2013.12.007  0.606
2013 Hansen C, Björklund T, Petit GH, Lundblad M, Murmu RP, Brundin P, Li JY. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Neurobiology of Disease. 56: 145-55. PMID 23643841 DOI: 10.1016/J.Nbd.2013.04.017  0.379
2013 Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Björklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proceedings of the National Academy of Sciences of the United States of America. 110: E1817-26. PMID 23610405 DOI: 10.1073/Pnas.1305623110  0.436
2013 Nevalainen N, Lundblad M, Gerhardt GA, Strömberg I. Striatal glutamate release in L-DOPA-induced dyskinetic animals. Plos One. 8: e55706. PMID 23390548 DOI: 10.1371/journal.pone.0055706  0.655
2012 Kirkeby A, Grealish S, Wolf DA, Nelander J, Wood J, Lundblad M, Lindvall O, Parmar M. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Reports. 1: 703-14. PMID 22813745 DOI: 10.1016/J.Celrep.2012.04.009  0.445
2012 Lundblad M, Decressac M, Mattsson B, Björklund A. Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 109: 3213-9. PMID 22315428 DOI: 10.1073/Pnas.1200575109  0.458
2012 Decressac M, Mattsson B, Lundblad M, Weikop P, Björklund A. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Neurobiology of Disease. 45: 939-53. PMID 22182688 DOI: 10.1016/J.Nbd.2011.12.013  0.47
2011 Nevalainen N, Af Bjerkén S, Lundblad M, Gerhardt GA, Strömberg I. Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. Journal of Neurochemistry. 118: 12-23. PMID 21534956 DOI: 10.1111/j.1471-4159.2011.07292.x  0.668
2010 Birgner C, Nordenankar K, Lundblad M, Mendez JA, Smith C, le Grevès M, Galter D, Olson L, Fredriksson A, Trudeau LE, Kullander K, Wallén-Mackenzie A. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 389-94. PMID 20018672 DOI: 10.1073/Pnas.0910986107  0.582
2009 Lundblad M, af Bjerkén S, Cenci MA, Pomerleau F, Gerhardt GA, Strömberg I. Chronic intermittent L-DOPA treatment induces changes in dopamine release. Journal of Neurochemistry. 108: 998-1008. PMID 19196428 DOI: 10.1111/j.1471-4159.2008.05848.x  0.673
2007 Cenci MA, Lundblad M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.25. PMID 18428668 DOI: 10.1002/0471142301.ns0925s41  0.471
2007 Valastro B, Dekundy A, Krogh M, Lundblad M, James P, Danysz W, Quack G, Cenci MA. Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia. Journal of Neurochemistry. 102: 1395-409. PMID 17532790 DOI: 10.1111/j.1471-4159.2007.04655.x  0.414
2007 Dekundy A, Lundblad M, Danysz W, Cenci MA. Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behavioural Brain Research. 179: 76-89. PMID 17306893 DOI: 10.1016/j.bbr.2007.01.013  0.448
2007 Lindgren HS, Rylander D, Ohlin KE, Lundblad M, Cenci MA. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration. Behavioural Brain Research. 177: 150-9. PMID 17157933 DOI: 10.1016/J.Bbr.2006.09.019  0.741
2006 Cenci MA, Lundblad M. Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. Journal of Neurochemistry. 99: 381-92. PMID 16942598 DOI: 10.1111/j.1471-4159.2006.04124.x  0.53
2006 Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. Journal of Neurochemistry. 96: 1718-27. PMID 16539687 DOI: 10.1111/J.1471-4159.2006.03696.X  0.687
2006 Carlsson T, Winkler C, Lundblad M, Cenci MA, Björklund A, Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiology of Disease. 21: 657-68. PMID 16256359 DOI: 10.1016/J.Nbd.2005.09.008  0.411
2005 Lundblad M, Usiello A, Carta M, HÃ¥kansson K, Fisone G, Cenci MA. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Experimental Neurology. 194: 66-75. PMID 15899244 DOI: 10.1016/J.Expneurol.2005.02.002  0.538
2004 Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiology of Disease. 17: 219-36. PMID 15474360 DOI: 10.1016/J.Nbd.2004.07.005  0.642
2004 Lundblad M, Picconi B, Lindgren H, Cenci MA. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiology of Disease. 16: 110-23. PMID 15207268 DOI: 10.1016/j.nbd.2004.01.007  0.648
2004 Stefanova N, Lundblad M, Tison F, Poewe W, Cenci MA, Wenning GK. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). Neurobiology of Disease. 15: 630-9. PMID 15056471 DOI: 10.1016/j.nbd.2003.11.025  0.492
2003 Lundblad M, Vaudano E, Cenci MA. Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia. Journal of Neurochemistry. 84: 1398-410. PMID 12614340 DOI: 10.1046/j.1471-4159.2003.01632.x  0.553
2002 Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. The European Journal of Neuroscience. 15: 120-32. PMID 11860512 DOI: 10.1046/J.0953-816X.2001.01843.X  0.659
2001 Westin JE, Andersson M, Lundblad M, Cenci MA. Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. The European Journal of Neuroscience. 14: 1171-6. PMID 11683909 DOI: 10.1046/J.0953-816X.2001.01743.X  0.728
Show low-probability matches.